Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasonic Nebulized Esketamine vs Dexmedetomidine for Pediatric Preoperative Sedation
ChiCTR2500115032Phase 4Not yet recruiting
- Sponsor
- Qixingguan District People's Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and dexmedetomidine in None (3 arms), sponsored by Qixingguan District People's Hospital. Primary endpoints: Success rate of sedation in children and Onset time of sedation. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
esketaminedexmedetomidine
Beyond the preview
Go deeper on ChiCTR2500115032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115032.